Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban
Status:
Completed
Trial end date:
2017-08-29
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of tranexamic acid versus placebo on perioperative blood
loss using two dosage regimens (standard and extended) after a surgery during total hip
arthroplasty in patients receiving the novel fast-acting oral anticoagulant rivaroxaban for
prophylaxis of thrombosis.